Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$12.3B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers across the United States....

Key Metrics to Watch

EPS Growth

Earnings per share (EPS) growth indicates the company's profitability and operational efficiency, which are crucial for investor confidence.

N/A

Patient Growth

An increase in patient numbers can signal effective service delivery and market demand, impacting future revenue.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers across the United States. As a key player in the health care sector, its performance is closely tied to trends in chronic disease management and health care spending.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, surpassing estimates by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Focus on improving patient care and operational efficiency.
Commitment to expanding service offerings in kidney care.
Plans to enhance technology integration in patient management.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given DaVita's recent performance and the health care sector's resilience.

Bull Case

If DaVita continues its trend of beating EPS estimates, it could see a significant stock price increase, reflecting strong operational performance.

Bear Case

Conversely, any signs of stagnation in patient growth or revenue could lead to a negative market reaction, especially if the company fails to meet expectations.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient growth rate compared to last quarter?

This metric will indicate how well DaVita is attracting and retaining patients, which is critical for future revenue.

How has operational efficiency improved in the last quarter?

Improvements in efficiency can lead to better margins and profitability, directly impacting EPS.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate DaVita's ability to expand its patient base significantly this quarter, given recent trends in chronic disease management.

Supporting Evidence

DaVita has consistently beaten EPS estimates in the past, indicating strong operational capabilities.

The health care sector is seeing increased spending, which could benefit DaVita's revenue.

Options pricing suggests a high level of expected volatility, indicating that investors are anticipating significant news.

Key Risk

If patient growth exceeds expectations, it could significantly alter the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether DaVita can maintain its growth trajectory amidst increasing competition and health care costs.

Bull Confirmed If

An EPS of $3.00 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.50 would raise concerns about profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational health.

In-Line / Cautious

An in-line report may lead to a muted response, as investors await further guidance on future growth.

Miss

A miss could result in a decline of around 0.78%, reflecting disappointment in performance and growth outlook.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on patient growth numbers and trends.
2Details on operational efficiency improvements.
3Any new initiatives or partnerships in kidney care.
4Insights into cost management strategies.
5Management's outlook on future revenue growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, operating dialysis centers across the United States....

Key Metrics to Watch

EPS Growth

Earnings per share (EPS) growth indicates the company's profitability and operational efficiency, which are crucial for investor confidence.

N/A

Patient Growth

An increase in patient numbers can signal effective service delivery and market demand, impacting future revenue.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1-2026, DaVita reported an EPS of $2.87, surpassing estimates by 19.09%. The stock reacted positively, gaining 1.92% the following day.

Management Promises & Guidance

Focus on improving patient care and operational efficiency.
Commitment to expanding service offerings in kidney care.
Plans to enhance technology integration in patient management.

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given DaVita's recent performance and the health care sector's resilience.

Bull Case

If DaVita continues its trend of beating EPS estimates, it could see a significant stock price increase, reflecting strong operational performance.

Bear Case

Conversely, any signs of stagnation in patient growth or revenue could lead to a negative market reaction, especially if the company fails to meet expectations.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient growth rate compared to last quarter?

This metric will indicate how well DaVita is attracting and retaining patients, which is critical for future revenue.

How has operational efficiency improved in the last quarter?

Improvements in efficiency can lead to better margins and profitability, directly impacting EPS.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate DaVita's ability to expand its patient base significantly this quarter, given recent trends in chronic disease management.

Supporting Evidence

DaVita has consistently beaten EPS estimates in the past, indicating strong operational capabilities.

The health care sector is seeing increased spending, which could benefit DaVita's revenue.

Options pricing suggests a high level of expected volatility, indicating that investors are anticipating significant news.

Key Risk

If patient growth exceeds expectations, it could significantly alter the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether DaVita can maintain its growth trajectory amidst increasing competition and health care costs.

Bull Confirmed If

An EPS of $3.00 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.50 would raise concerns about profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational health.

In-Line / Cautious

An in-line report may lead to a muted response, as investors await further guidance on future growth.

Miss

A miss could result in a decline of around 0.78%, reflecting disappointment in performance and growth outlook.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on patient growth numbers and trends.
2Details on operational efficiency improvements.
3Any new initiatives or partnerships in kidney care.
4Insights into cost management strategies.
5Management's outlook on future revenue growth.